1. A Phase II Trial Evaluating the Efficacy and Safety of Efavirenz in Metastatic Castration-Resistant Prostate Cancer. (29th October 2014) Authors: Houédé, Nadine; Pulido, Marina; Mourey, Loic; Joly, Florence; Ferrero, Jean-Marc; Bellera, Carine; Priou, Frank; Lalet, Caroline; Laroche-Clary, Audrey; Raffin, Mireille Canal; Ichas, François; Puech, Alain; Piazza, Pierre Vincenzo Journal: Oncologist Issue: Volume 19:Number 12(2014) Page Start: 1227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase II Trial Evaluating the Efficacy and Safety of Efavirenz in Metastatic Castration‐Resistant Prostate Cancer. (29th October 2014) Authors: Houédé, Nadine; Pulido, Marina; Mourey, Loic; Joly, Florence; Ferrero, Jean‐Marc; Bellera, Carine; Priou, Frank; Lalet, Caroline; Laroche‐Clary, Audrey; Raffin, Mireille Canal; Ichas, François; Puech, Alain; Piazza, Pierre Vincenzo Journal: Oncologist Issue: Volume 19:Number 12(2014) Page Start: 1227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design. Issue 10336 (30th April 2022) Authors: Fizazi, Karim; Foulon, Stéphanie; Carles, Joan; Roubaud, Guilhem; McDermott, Ray; Fléchon, Aude; Tombal, Bertrand; Supiot, Stéphane; Berthold, Dominik; Ronchin, Philippe; Kacso, Gabriel; Gravis, Gwenaëlle; Calabro, Fabio; Berdah, Jean-François; Hasbini, Ali; Silva, Marlon; Thiery-Vuillemin, Antoi... Journal: Lancet Issue: Volume 399:Issue 10336(2022) Page Start: 1695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial. Issue 7 (July 2015) Authors: Fizazi, Karim; Faivre, Laura; Lesaunier, François; Delva, Remy; Gravis, Gwenaëlle; Rolland, Frédéric; Priou, Frank; Ferrero, Jean-Marc; Houede, Nadine; Mourey, Loïc; Theodore, Christine; Krakowski, Ivan; Berdah, Jean-François; Baciuchka, Marjorie; Laguerre, Brigitte; Fléchon, Aude; Ravaud, Alain;... Journal: Lancet oncology Issue: Volume 16:Issue 7(2015:Jul.) Page Start: 787 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cabazitaxel activity in men with metastatic castration-resistant prostate cancer with and without DNA damage repair defects. (December 2021) Authors: Aldea, Mihaela; Lam, Laurent; Orillard, Emeline; Llacer Perez, Casilda; Saint-Ghislain, Mathilde; Gravis, Gwenaelle; Fléchon, Aude; Roubaud, Guilhem; Barthelemy, Philippe; Ricci, Francesco; Priou, Frank; Neviere, Zoe; Beaufils, Mathilde; Laguerre, Brigitte; Hardy, Anne-Claire; Helissey, Carole; R... Journal: European journal of cancer Issue: Volume 159(2021) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database. (January 2020) Authors: Delanoy, Nicolas; Hardy-Bessard, Anne-Claire; Efstathiou, Eleni; Le Moulec, Sylvestre; Basso, Umberto; Birtle, Alison; Thomson, Alastair; Krainer, Michael; Guillot, Aline; De Giorgi, Ugo; Hasbini, Ali; Daugaard, Gedske; Bahl, Amit; Chowdhury, Simon; Caffo, Orazio; Beuzeboc, Philippe; Spaeth, Domi... Journal: European journal of cancer Issue: Volume 125(2020) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Corrigendum to "Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database" [Eur J Canc 125, (January 2020) 153–163]. (September 2020) Authors: Delanoy, Nicolas; Hardy-Bessard, Anne-Claire; Efstathiou, Eleni; Le Moulec, Sylvestre; Basso, Umberto; Birtle, Alison; Thomson, Alastair; Krainer, Michael; Guillot, Aline; De Giorgi, Ugo; Hasbini, Ali; Daugaard, Gedske; Bahl, Amit; Chowdhury, Simon; Caffo, Orazio; Beuzeboc, Philippe; Spaeth, Domi... Journal: European journal of cancer Issue: Volume 137(2020) Page Start: 288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study. (March 2023) Authors: Velev, Maud; Dalban, Cécile; Chevreau, Christine; Gravis, Gwenaelle; Negrier, Sylvie; Laguerre, Brigitte; Gross-Goupil, Marine; Ladoire, Sylvain; Borchiellini, Delphine; Geoffrois, Lionnel; Joly, Florence; Priou, Frank; Barthelemy, Philippe; Laramas, Mathieu; Narciso, Berangère; Thiery-Vuillemin,... Journal: European journal of cancer Issue: Volume 182(2023) Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Erratum to 'Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database' [European Journal of Cancer, Volume 125 (January 2020) Pages 153–163]. (September 2020) Authors: Delanoy, Nicolas; Hardy-Bessard, Anne-Claire; Efstathiou, Eleni; Moulec, Sylvestre Le; Basso, Umberto; Birtle, Alison; Thomson, Alastair; Krainer, Michael; Guillot, Aline; Giorgi, Ugo De; Hasbini, Ali; Daugaard, Gedske; Bahl, Amit; Chowdhury, Simon; Caffo, Orazio; Beuzeboc, Philippe; Spaeth, Domi... Journal: European journal of cancer Issue: Volume 137(2020) Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. MP27-13 LONG-TERM SAFETY OF DAROLUTAMIDE AMONG PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WHO RECEIVED MORE THAN 4 YEARS OF THERAPY. (May 2022) Authors: Jones, Robert Hugh; Fizazi, Karim; James, Nicholas D.; Tammela, Teuvo L.; Matsubara, Nobuaki; Priou, Frank; Beuzeboc, Phillipe; Lesimple, Thierry; Bono, Petri; Kataja, Vesa; Garcia, Jorge A.; Protheroe, Andrew; Aspegren, John; Joensuu, Heikki; Kuss, Iris; Thiele, Silke; Fiala-Buskies, Sabine; Vja... Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e455 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗